Shelton Capital Management Abbott Laboratories Transaction History

Shelton Capital Management

  • $3.62 Billion
  • Q2 2024

A detailed history of Shelton Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Shelton Capital Management holds 27,583 shares of ABT stock, worth $3.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
27,583
Previous 27,585 0.01%
Holding current value
$3.1 Million
Previous $3.14 Million 8.58%
% of portfolio
0.08%
Previous 0.09%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $201 - $224
-2 Reduced 0.01%
27,583 $2.87 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $1.5 Million - $1.66 Million
-13,703 Reduced 33.19%
27,585 $3.14 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $519,494 - $635,904
-5,760 Reduced 12.24%
41,288 $4.54 Million
Q2 2023

Aug 10, 2023
SELL
$100.78 - $112.29 $669,985 - $746,503
-6,648 Reduced 12.38%
47,048 $5.13 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $2.37 Million - $2.79 Million
24,496 Added 83.89%
53,696 $5.44 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $3.27 Million - $3.83 Million
-34,373 Reduced 54.07%
29,200 $3.21 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $39,865 - $46,156
-412 Reduced 0.64%
63,573 $6.15 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $5,613 - $6,785
-55 Reduced 0.09%
63,985 $6.95 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $510,581 - $622,621
-4,478 Reduced 6.54%
64,040 $7.58 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $381,017 - $466,535
3,298 Added 5.06%
68,518 $9.64 Million
Q3 2021

Nov 15, 2021
SELL
$116.66 - $129.06 $4.24 Million - $4.69 Million
-36,366 Reduced 35.8%
65,220 $7.7 Million
Q2 2021

Aug 12, 2021
BUY
$105.79 - $124.53 $930,952 - $1.1 Million
8,800 Added 9.48%
101,586 $11.8 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $990,335 - $1.17 Million
-9,099 Reduced 8.93%
92,786 $11.1 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $5.23 Million - $5.7 Million
-49,786 Reduced 32.82%
101,885 $11.2 Million
Q3 2020

Nov 09, 2020
SELL
$91.64 - $111.29 $1.19 Million - $1.45 Million
-13,025 Reduced 7.91%
151,671 $16.5 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $290,889 - $372,302
-3,799 Reduced 2.25%
164,696 $15.1 Million
Q1 2020

May 13, 2020
SELL
$62.82 - $91.86 $844,614 - $1.24 Million
-13,445 Reduced 7.39%
168,495 $13.3 Million
Q4 2019

Feb 11, 2020
BUY
$78.51 - $87.4 $1.86 Million - $2.08 Million
23,747 Added 15.01%
181,940 $15.8 Million
Q3 2019

Nov 13, 2019
BUY
$81.84 - $88.74 $890,828 - $965,934
10,885 Added 7.39%
158,193 $13.2 Million
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $10.1 Million - $11.8 Million
138,976 Added 1667.98%
147,308 $12.4 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $4.1 Million - $4.95 Million
-61,889 Reduced 88.13%
8,332 $104 Million
Q4 2018

Jan 31, 2019
SELL
$65.56 - $74.27 $39,336 - $44,562
-600 Reduced 0.85%
70,221 $5.08 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $3,891 - $4,695
-64 Reduced 0.09%
70,821 $5.2 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $16,465 - $18,172
-286 Reduced 0.4%
70,885 $4.32 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $261,430 - $295,578
-4,646 Reduced 6.13%
71,171 $4.27 Million
Q4 2017

Feb 06, 2018
SELL
$53.68 - $57.47 $123,464 - $132,181
-2,300 Reduced 2.94%
75,817 $4.33 Million
Q3 2017

Nov 14, 2017
SELL
$48.06 - $53.64 $5.04 Million - $5.63 Million
-104,917 Reduced 57.32%
78,117 $4.17 Million
Q2 2017

Aug 14, 2017
BUY
N/A
34,783 Added 23.46%
183,034 $8.9 Million
Q1 2017

Nov 28, 2017
BUY
N/A
9,211 Added 6.62%
148,251 $6.58 Million
Q4 2016

Nov 29, 2017
BUY
N/A
56,333 Added 68.11%
139,040 $5.34 Million
Q3 2016

Dec 06, 2017
SELL
N/A
-56,333 Reduced 40.52%
82,707 $3.5 Million
Q3 2016

Dec 04, 2017
BUY
N/A
139,040
139,040 $5.34 Million

Others Institutions Holding ABT

# of Institutions
3,135
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email